What are the first‑line management options for molluscum contagiosum in an immunocompetent individual?

First-Line Management of Molluscum Contagiosum in Immunocompetent Individuals

For immunocompetent patients, watchful waiting is reasonable for asymptomatic, limited lesions, while physical removal methods (curettage, cryotherapy, or excision) are first-line therapy for symptomatic lesions, multiple lesions, or periocular involvement. 1, 2

Treatment Algorithm

Step 1: Assess Need for Active Treatment

Watchful waiting is appropriate when:

• Lesions are asymptomatic 2
• Limited number of lesions present 2
• No periocular involvement 2
• Patient/family accepts spontaneous resolution timeline of 6-12 months (though can extend to 4-5 years) 1, 2

Active treatment is indicated for:

• Symptomatic lesions (painful, pruritic, or inflamed) 1, 2
• Multiple or numerous lesions 1, 2
• Lesions near the eyes causing conjunctivitis 1, 2
• Cosmetic concerns or psychosocial distress 1
• Prevention of autoinoculation and transmission 2

Step 2: Select First-Line Treatment Modality

Physical removal methods (recommended by the American Academy of Ophthalmology):

• Cryotherapy with liquid nitrogen: Achieves complete response in approximately 93% of cases 1, 2
• Curettage, simple excision, or excision with cautery: Equally effective first-line options 1, 3

Chemical destruction (recommended by the American Academy of Pediatrics):

• 10% potassium hydroxide solution: Similar efficacy to cryotherapy (86.6% vs 93.3% complete response) with better cosmetic results due to lower risk of hyperpigmentation 1, 2
• Cantharidin: Effective in observational studies with 86% parent satisfaction and no serious adverse events in large retrospective review of 405 children 1

Step 3: Treatment Execution

When treating, you must:

• Identify and treat ALL lesions, including nascent (early) ones, as missing these is a common cause of recurrence 1, 3
• Reducing viral load allows the host immune response to eliminate residual virus 1, 3

For periocular lesions with conjunctivitis:

• Physical removal is imperative 1, 2
• Monitor for resolution of conjunctivitis, which may require several weeks after lesion elimination 1, 3

Important Caveats and Pitfalls

Cosmetic considerations:

• Cryotherapy carries higher risk of postinflammatory hyperpigmentation or scarring, particularly concerning for facial lesions or darker skin tones 1, 2
• Potassium hydroxide confers better cosmetic outcomes 1
• Avoid cryotherapy on sensitive areas (eyelids, lips, nose, ears) due to higher complication risk 1

Treatments to AVOID:

• Imiquimod is NOT effective and showed no benefit compared to placebo in randomized controlled trials 1, 2
• Salicylic acid is contraindicated in children under 2 years due to systemic toxicity risk 2

Red flags requiring further evaluation:

• Multiple large lesions with minimal inflammation suggest possible immunocompromised state and warrant screening 1, 3
• Extensive or recalcitrant disease requires dermatology referral 1, 3

Prevention and Transmission Control

Essential prevention measures:

• Hand hygiene with alcohol-based disinfectant or soap and water is the most important prevention method 1, 2
• Avoid sharing towels, clothing, and personal items 1, 2
• Cover all lesions with waterproof bandages if water exposure unavoidable 1, 2
• Limit exposure to swimming pools and hot tubs associated with known outbreaks 1